STAT Breakthrough Summit 2025 - East | STAT | 20 March 2025 | Cure, 345 Park Ave S, New York, NY 10010, USA

Fewer than one in 10 medicines that make it to in-human studies actually reach patients, a statistic so consistent it feels like a law of nature. But there is emerging progress in the effort to deliver new treatments to patients faster.

At this event, we’ll survey the field, exploring the intricacies of new biology, animal testing, and tech advancements that are driving more productive clinical research. We’ll highlight lessons learned and victories achieved at each step of the process, including those related to the growing role that patients play in development. Join us to see how leaders in biotech are reshaping R&D and what history teaches researchers and industry professionals.

Why Attend?
Innovative Speakers:
• Industry-shaping leaders take the stage for thought-provoking conversations, with live audience questions and discussion
Impactful Live Journalism:
• Our award-winning journalism brought to life by STAT’s editorial team, on stage and reporting directly from the summit floor
Influential Audience:
• Top voices from the lab to the C-suite come together, alongside policymakers, patient advocates, and more

2025 Speakers

MODERATORS:

Rick Berke
Co-Founder & Executive Editor, STAT

Torie Bosch
Editor, First Opinion, STAT

Laura Chang
Editorial Director, STAT

Allison DeAngelis
Biotech Startups and Venture Capital Reporter, STAT

Adam Feuerstein
Senior Writer, Biotech, STAT

Gideon Gil
Managing Editor, STAT

Matthew Herper
Senior Writer, Medicine; Editorial Director of Events, STAT

Lizzy Lawrence
FDA Reporter, STAT

Anil Oza
Sharon Begley Science Reporting Fellow, STAT

Katie Palmer
Health Tech Correspondent, STAT

Jonathan Wosen
West Coast Biotech & Life Sciences Reporter, STAT

SPEAKERS:

Andrew Baum
Chief Scientific and Innovation Officer, Pfizer

Tyler Allchin
Managing Director, Healthcare, JobsOhio

Des Creary
Chief Customer Engagement Officer, Novartis US

Melissa Dupont
Global Public Affairs Lead, Neurology Pipeline, Sanofi

Holly Fernandez Lynch, J.D.
Associate Professor of Medical Ethics and Law, University of Pennsylvania

Scott Gottlieb, M.D.
Senior Fellow, American Enterprise Institute

Josh Hoffman
Director, Healthcare, JobsOhio

Carole Huntsman
Chief Commercial Officer, Madrigal Pharma

Jonathan Jackson, Ph.D.
Co-Founder & Research Director, CRESCENT Consulting

Seema Kumar
Chief Executive Officer, Cure

Lonny R. Levin, Ph.D.
Professor of Pharmacology, Weill Cornell Medicine

Bill Nye
Science Educator

Viq Pervaaz
Senior Vice President, Life Sciences and Healthcare, NYCEDC

Zach Reitano
CEO & Co-Founder, Ro

Andrew Rosen
Chief Executive Officer, National Ataxia Foundation

Janelle Sabo, PharmD, RPh, MBA
Senior Vice President, Clinical Capabilities, Eli Lilly & Co.

Melissa Simon, M.D.
George H. Gardner Professor of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine

Ken Song, M.D.
Chairman, President & CEO, Candid Therapeutics

Owen Tripp
Co-Founder & CEO, Included Health

Leslie Oley Wilberforce
President, Evidation

James Wilson, M.D., Ph.D.
President & CEO, GEMMABio; Chairperson, Franklin Biolabs

Gillian Woollet, MA, DPhil
VP, Head Regulatory Strategy and Policy, Samsung Bioepis

Kitty Yale
Chief Development Officer, Akero Therapeutics

2025 Sponsors

PREMIUM SPONSORS:
• Evidation
• Life Sci
• Lilly
• Novartis
• Samsung Bioepis
• Ultragenyx

STAT MADNESS SPONSORS:
• Ohio Discovery Corridor
• Cure Wewillcure.com

SUPPORTING SPONSOR:
• Sanofi